JPMorgan analyst Jessica Fye resumes coverage on Legend Biotech Corp. (NASDAQ: LEGN) with a Neutral rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage